Hybrid Immunity and the Incidence of SARS-CoV-2 Reinfections during the Omicron Era in Frontline Healthcare Workers

被引:0
|
作者
Chivu, Carmen-Daniela [1 ,2 ]
Craciun, Maria-Dorina [1 ,2 ]
Pitigoi, Daniela [1 ,3 ]
Arama, Victoria [3 ,4 ]
Luminos, Monica Luminita [3 ,5 ]
Jugulete, Gheorghita [3 ,5 ]
Nitescu, Viorela Gabriela [2 ,6 ]
Lescaie, Andreea [2 ,6 ]
Apostolescu, Catalin Gabriel [3 ,4 ]
Streinu Cercel, Adrian [3 ,4 ]
机构
[1] Carol Davila Univ Med & Pharm, Dept Epidemiol 1, Bucharest 050474, Romania
[2] Emergency Clin Hosp Children Grigore Alexandrescu, Bucharest 011743, Romania
[3] Natl Inst Infect Dis Prof Dr Matei Bals, Bucharest 021105, Romania
[4] Carol Davila Univ Med & Pharm, Dept Infect Dis 1, Bucharest 020021, Romania
[5] Carol Davila Univ Med & Pharm, Dept Infect Dis 3, Bucharest 020021, Romania
[6] Carol Davila Univ Med & Pharm, Dept Pediat, Bucharest 020021, Romania
关键词
SARS-CoV-2; reinfection; healthcare workers; vaccines protection; variant of concern;
D O I
10.3390/vaccines12060682
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During the coronavirus disease (COVID-19) pandemic healthcare workers (HCWs) acquired immunity by vaccination or exposure to multiple variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Our study is a comparative analysis between subgroups of HCWs constructed based on the number of SARS-CoV-2 infections, vaccination, and the dominant variant of SARS-CoV-2 in the population. We collected and analyzed data using the chi 2 test and density incidence of reinfections in Microsoft Excel for Mac, Version 16.84, and MedCalc (R), 22.026. Of the 829 HCWs, 70.1% (581) had only one SARS-CoV-2 infection and 29.9% (248) had two infections. Of the subjects with two infections, 77.4% (192) worked in high-risk departments and 93.2% (231) of the second infections were registered during Omicron dominance. The density incidence of reinfections was higher in HCWs vaccinated with the primary schedule than those vaccinated with the first booster, and the incidence ratio was 2.8 (95% CI: 1.2; 6.7). The probability of reinfection was five times lower (95% CI: 2.9; 9.2) in HCWs vaccinated with the primary schedule if the first infection was acquired during Omicron dominance. The subjects vaccinated with the first booster had a density incidence of reinfection three times lower (95% CI: 1.9; 5.8) if the first infection was during Omicron. The incidence ratio in subgroups constructed based on characteristics such as gender, age group, job category, and department also registered significant differences in density incidence. The history of SARS-CoV-2 infection by variant is important when interpreting and understanding public health data and the results of studies related to vaccine efficacy for hybrid immunity subgroup populations.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] SARS-CoV-2 seropositivity amongst healthcare workers in South Africa during the Omicron wave: natural infection versus vaccination
    Hoffmann, Daniel J.
    Meyer, Pieter W. A.
    Worsley, Catherine M.
    van der Mescht, Mieke A.
    Visser, A.
    Pillay, Tahir S.
    JOURNAL OF CLINICAL PATHOLOGY, 2025,
  • [32] An Overview About the Role of Adaptive Immunity in Keeping SARS-CoV-2 Reinfections at Bay
    Ahsan, Haseeb
    Sonn, Jong Kyung
    Lee, Young Sup
    Ul Islam, Salman
    Khalil, Saifullah Khan
    VIRAL IMMUNOLOGY, 2021, 34 (09) : 588 - 596
  • [33] Genomic Epidemiology of the Main SARS-CoV-2 Variants Circulating in Italy During the Omicron Era
    Bergna, Annalisa
    Lai, Alessia
    Sagradi, Fabio
    Menzo, Stefano
    Mancini, Nicasio
    Bruzzone, Bianca
    Rusconi, Stefano
    Marchegiani, Greta
    Clementi, Nicola
    Francisci, Daniela
    Vicenti, Ilaria
    Ronchiadin, Silvia
    Mbissam, Harcel Djaya
    della Ventura, Carla
    Lanfranchi, Leonardo
    Testa, Sophie
    Caucci, Sara
    Acciarri, Carla
    Carioti, Luca
    Occhionero, Alessandro
    Novazzi, Federica
    Genoni, Angelo Paolo
    Ferrante, Francesca Drago
    De Pace, Vanessa
    Ferraris, Monica
    Ogliastro, Matilde
    Gabrieli, Arianna
    De Paschale, Massimo
    Canavesi, Giada
    Bellocchi, Maria Concetta
    Iannetta, Marco
    Sarmati, Loredana
    Ceccherini-Silberstein, Francesca
    Riva, Agostino
    Antinori, Spinello
    Zehender, Gianguglielmo
    JOURNAL OF MEDICAL VIROLOGY, 2025, 97 (02)
  • [34] Usefulness of universal SARS-CoV-2 PCR testing for inpatients and their caregivers during the omicron era
    Jung, Jiwon
    Yang, Hyejin
    Park, Soyeon
    Lim, Hyun-Jung
    Kim, Sun-Kyung
    Lim, Young-Ju
    Kim, Eun Ok
    Kim, Sung-Han
    HELIYON, 2022, 8 (10)
  • [35] Observational study on healthcare workers protection in the angiographic suite during the SARS-CoV-2 pandemic: before and during vax era
    Cernigliaro, Massimiliano
    Negroni, Davide
    Sassone, Miriana
    Paladini, Andrea
    Carriero, Alessandro
    Saba, Luca
    Guzzardi, Giuseppe
    JOURNAL OF PUBLIC HEALTH RESEARCH, 2021, 10 (04)
  • [36] The different epidemiological questions on SARS-CoV-2 reinfections
    Procter, Simon R.
    Goncalves, Bronner P.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2023, 52 (03) : 958 - 959
  • [37] Pathogenicity of SARS-CoV-2 Omicron
    Chu, Hin
    Yuen, Kwok-Yung
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (05):
  • [38] Incidence of SARS-CoV-2 infection among unvaccinated US adults during the Omicron wave
    Alejo, Jennifer L.
    Chiang, Teresa P. Y.
    Mitchell, Jonathan
    Abedon, Aura T.
    Jefferis, Alexa A.
    Werbel, William
    Massie, Allan B.
    Makary, Martin A.
    Segev, Dorry L.
    JOURNAL OF INTERNAL MEDICINE, 2022, 292 (06) : 965 - 968
  • [39] Declining Levels of Neutralizing Antibodies to SARS-CoV-2 Omicron Variants Are Enhanced by Hybrid Immunity and Original/Omicron Bivalent Vaccination
    Walmsley, Sharon
    Nabipoor, Majid
    Qi, Freda
    Lovblom, Leif Erik
    Ravindran, Rizani
    Colwill, Karen
    Dayam, Roya Monica
    Tursun, Tulunay R.
    Silva, Amanda
    Gingras, Anne-Claude
    VACCINES, 2024, 12 (06)
  • [40] Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel disease
    Alirezaylavasani, Amin
    Egner, Ingrid Marie
    Dahl, Borresdatter
    Chopra, Adity
    Kasahara, Taissa de Matos
    Goll, Guro Lovik
    Jahnsen, Jorgen
    Grodeland, Gunnveig
    Vaage, John Torgils
    Lund-Johansen, Fridtjof
    Holter, Jan Cato
    Halvorsen, Bente
    Jorgensen, Kristin Kaasen
    Munthe, Ludvig A.
    Kared, Hassen
    CLINICAL IMMUNOLOGY, 2025, 271